Kane Biotech was preparing the annual financial statements and, as part of the year-end procedures, assessed the assets and prepared the following alphabetized schedule based on adjusted values at December 31, 2020. (Do not round Intermediate calculations. Round inal answers to nearest whole dollar) IleCoreable Equit Turniture Land Die bailding Warehouse Date of Purchase May 1/15 Jun 20/15 Apr 5/15 Apr 5/15 Apr. 5/15 Depke Method Unit: N/A 3L 31. Cont $47.000 19, ODD 92.000 91.000 65,500 lesdal V 3. 110 2.700 N/A 29, 200 17,000 Ore Lite 2.700 units YA N/A 15 KM 20 YARI 26,790 15.599 N/N 29. 200 1.928 5.110 2.650 100. EDD 50, 500 52.100 *DDB - Double declining balance SL - Straight line: Units - Units of production, NA Not applicable Required: 1. Record any Impalment losses at December 31, 2020. Assume Kane Biotech has recorded no Implant losses in previous years. 1. Record any Impalment losses at December 31, 2020. Assume Kane Biotech has recorded no impairment losses in previous years. View transaction list Journal entry worksheet > Record impairment loss on PPE, if any. Noter-Enter debits before credits. General Journal Debit Credit Dec 31 2020 Record entry Clear entry View general journal ? Bermiere inn for each 755 teremher 12021 Assume that there was no change in the residual values or useful lives 2. Record depreciation for each asset at December 31, 2021. Assume that there was no change in the residual values or useful lives regardless of any impairment losses that might have occurred. The equipment produced 2,150 units during 2021. View transaction list Journal entry worksheet 1 Record the revised depreciation on equipment. Note: Enter debts before credits General Journal Debit Credit December 31, 2021 Record entry Cuar entry View general journal